Work

An Unusual Therapy for an Atypical Case of Secondary Extranodal, Non-parenchymal Central Nervous System Marginal Zone Lymphoma

Year: 2025

Type: article

Abstract: Marginal zone lymphomas (MZL) are low-grade B-cell neoplasms with indolent clinical behavior and a favorable prognosis. Central nervous system (CNS) involvement is extremely rare in MZL, as in other low-grade lymphomas where some presented with primary CNS disease without involvement elsewhere, and only a few cases were secondary to MZL. The dura mater is the most common site of involvement, while cavernous sinus involvement is extremely rare. There are no specific treatment recommendations for patients with secondary CNS-MZL exhibiting an indolent course. Therapeutic trials and recommendations typically focus on aggressive lymphomas with a poor prognosis, where induction with intensive chemotherapy, including high-dose methotrexate and/or cytarabine, followed by autologous stem cell transplantation, is standard. We present the case of a 50-year-old man with MZL involving the cavernous sinus, who initially presented with neurological and ophthalmological symptoms and was successfully treated with high-dose methotrexate and the CHOP (cyclophosphamide, doxorubicin, vincristine, and prednisone) regimen.

Source: Cureus

DOI: 10.7759/cureus.79468

Authors: Siham Ahchouch, Abdelilah El Barrichi, Mohammed Allaoui, Hicham El Maaroufi, Kamal Doghmi

Institutions: Cadi Ayyad University, Hôpital Militaire Avicenne, Mohammed V University

Language: English

Topic: CNS Lymphoma Diagnosis and Treatment

Subfield: Neurology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: diamond

OpenAlex ID: W4407853675